Substrate for development of atrial fibrillation in patients with congestive heart failure: Are we close to the answer?

Heart Rhythm

Volumn 6, Issue 4, 2009, Pages 452-453

  Platonov, Pyotr G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DOFETILIDE;

ACTION POTENTIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE COURSE; EDITORIAL; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REFRACTORY PERIOD; HUMAN; INCIDENCE; MITRAL VALVE STENOSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ACTION POTENTIALS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 62549136940     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.01.014     Document Type: Editorial

References (16)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 112 (2005) e154-e235
2. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSU0S). N Engl J Med 316 (1987) 1429-1435
3. Zareba W., Steinberg J.S., McNitt S., et al. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm 3 (2006) 631-637
4. Singh S.N., Poole J., Anderson J., et al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J 152 (2006) 974.e7-974.e11
5. Swedberg K., Olsson L.G., Charlesworth A., et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 26 (2005) 1303-1308
6. Bunch T.J., Day J.D., Olshansky B., et al. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. Heart Rhythm 6 (2009) 2-8
7. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
8. Workman A.J., Pau D., Redpath C.J., et al. Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm 6 (2009) 445-451
9. Sanders P., Morton J.B., Davidson N.C., et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108 (2003) 1461-1468
10. Eckardt L., Kirchhof P., Breithardt G., et al. Load-induced changes in repolarization: evidence from experimental and clinical data. Basic Res Cardiol 96 (2001) 369-380
11. Huang J.L., Tai C.T., Chen J.T., et al. Effect of atrial dilatation on electrophysiologic properties and inducibility of atrial fibrillation. Basic Res Cardiol 98 (2003) 16-24
12. Li D., Fareh S., Leung T.K., et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100 (1999) 87-95
13. John B., Stiles M.K., Kuklik P., et al. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J 29 (2008) 2234-2243
14. Severs N.J., Bruce A.F., Dupont E., et al. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80 (2008) 9-19
15. Roy D., Talajic M., Dubuc M., et al. Atrial fibrillation and congestive heart failure. Curr Opin Cardiol 24 (2009) 29-34
16. Holmqvist F., Platonov P., Carlson J., et al. Altered inter-atrial conduction detected in MADIT II patients bound to develop atrial fibrillation. Ann Noninvas Electrocardiol (2009) (In press)